Synthetic Biology Company 'Sconry Biopharma' Completes Pre-A Round Financing, Focusing on Biological Fermentation and Enzyme Catalysis Technology Research, with Strategic Layout in Bio-based Materials and Health Sectors
In July 2024, Sconry Biopharma (Shanghai) Co., Ltd. successfully completed its Pre-A round of financing, co-invested by Mr. He Haichao, Chairman of JW Machinery and Chairman of JW Fund, and Mr. Xie Youbang and Mr. Fang Ying, founding partners of JW Fund. This round of financing will be used for research and development in biological fermentation and enzyme catalysis technology, with a strategic focus on bio-based materials and the health sector.
Learn More
Nobel Prize in Chemistry Awarded to Hassabis and Others for Protein Prediction, Marking AI for Science; Physics Prize Reflects Science for AI
In 2024, another Nobel Prize went to AI! This time, it was the Nobel Prize in Chemistry! Half of the award went to David Baker from the University of Washington for his contributions to protein computational design, and the other half went to Demis Hassabis and John M. Jumper of Google DeepMind for their work on protein structure prediction.
Learn More
Wuhu Gears Up! Aiming for a Synthetic Biology Industry Worth 100 Billion RMB by 2030!
[SynBioCon] reports that on September 30, the Wuhu Municipal Science and Technology Bureau officially released the 'Wuhu City Synthetic Biology Industry Development Action Plan (2024-2027),' aiming to seize new opportunities in the global biotech revolution and the transformation of science and technology industries, accelerate the construction of a synthetic biology industry ecosystem, and promote Wuhu as the new engine for the province's sub-central city. The action plan outlines a clear roadmap for the development of Wuhu's synthetic biology industry.
Learn More